APA (7th ed.) Citation

Martins, F., Sofiya, L., Sykiotis, G. P., Lamine, F., Maillard, M., Fraga, M., . . . Obeid, M. (2019). Adverse effects of immune-checkpoint inhibitors: Epidemiology, management and surveillance. Nature reviews. Clinical oncology, 16(9), 563-580. https://doi.org/10.1038/s41571-019-0218-0

Chicago Style (17th ed.) Citation

Martins, Filipe, et al. "Adverse Effects of Immune-checkpoint Inhibitors: Epidemiology, Management and Surveillance." Nature Reviews. Clinical Oncology 16, no. 9 (2019): 563-580. https://doi.org/10.1038/s41571-019-0218-0.

MLA (9th ed.) Citation

Martins, Filipe, et al. "Adverse Effects of Immune-checkpoint Inhibitors: Epidemiology, Management and Surveillance." Nature Reviews. Clinical Oncology, vol. 16, no. 9, 2019, pp. 563-580, https://doi.org/10.1038/s41571-019-0218-0.